CSNK1A1 and neurodegenerative disease: Since deregulation of CK1 isoforms have been linked to the development of various types of disorders such as cancer (CK1α/γ/δ/ε), neurodegenerative diseases (CK1δ), and inflammatory disorders (CK1α/δ/ε), the use of CK1 (isoform)-specific inhibitors may have therapeutic potential in the cure of these diseases (Gill et al. 2007; Knippschild et al. 2005a; Lin and Peng 2006; Perez et al. 2010).